Status:
RECRUITING
The Digital Version of Holistic Healthy Life Education(e2HLE)
Lead Sponsor:
The Hong Kong Polytechnic University
Collaborating Sponsors:
Yan Chai Hospital
Conditions:
Hypertension
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The digital version of Holistic Healthy Life Education" (e2HLE) is a holistic, person-centric, multi-component and lifestyle modification intervention that we developed, alongside the WHO integrated c...
Eligibility Criteria
Inclusion
- aged 50 years old or above,
- able to use internet and tablet;
- education level of primary or above;
- understand Chinese and speak Cantonese;
- have central obesity (waist circumference: male \>90 cm, female \>80 cm) and two of the following: (a) hypertension (systolic blood pressure ≥130 or diastolic blood pressure ≥85 mmHg, or treatment of previously diagnosed hypertension), (b) hyperglycemia (fasting plasma glucose ≥100 mg/dL (5.6 mmol/L) or (c) previously diagnosed type 2 diabetes), (d) hyperlipidemia (triglyceride concentrations ≥150 mg/dL (1.7 mmol/L), or treatment for this lipid abnormality); HDL cholesterol;40 mg/dL (1.03 mmol/L) in males and 50 mg/dL (1.29 mmol/L) in females, or treatment for this lipid abnormality), (e) BMI over 23; and chronic pain or bad mood caused by the psychosomatic disorder for no less than six months
- have at least 2 of the following distressing symptoms due to psychosomatic or pain and stress symptoms, including physical and mental agitation, feeling tired, often crying, feeling angry/depressed, feeling isolated from family and friends, feeling great stress, insomnia, health is worse than before.
Exclusion
- non-Chinese nationality or can't speak Cantonese;
- participating in any cancer treatment;
- will leave Hong Kong within a short period or the next three months;
- participating in another experiment; living in or planning to live in a facility-care home;
- cognitive difficulties (SPMSQ score equal to or lower than 4);
- taking medications such as estrogenic, synthetic glucocorticoids, anti-steroids, and antiepileptic drugs which may affect cortisol levels.
Key Trial Info
Start Date :
June 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 21 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06499961
Start Date
June 22 2024
End Date
May 21 2026
Last Update
July 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yan Chai Hospital Social Services Department
Hong Kong, Hong Kong